As of 2026-09-20, the Relative Valuation of Biodesix, Inc. (BDSX) is (38.39) USD. This relative valuation is based on P/E multiples. With the latest stock price at 29.20 USD, the upside of Biodesix, Inc. based on Relative Valuation is -231.5%.
The range of the Relative Valuation is (34.46) - (48.77) USD.
Note: valuation result may not be accurate due to the company's negative earnings.
| Range | Selected | |
| Trailing P/E multiples | 12.9x - 18.7x | 14.8x |
| Forward P/E multiples | 12.1x - 18.2x | 13.8x |
| Fair Price | (34.46) - (48.77) | (38.39) |
| Upside | -218.0% - -267.0% | -231.5% |
| Date | P/E |
| 2026-09-18 | -10.90 |
| 2026-09-17 | -10.75 |
| 2026-09-16 | -10.66 |
| 2026-09-15 | -10.34 |
| 2026-09-14 | -10.22 |
| 2026-09-11 | -10.06 |
| 2026-09-10 | -9.72 |
| 2026-09-09 | -10.11 |
| 2026-09-08 | -9.94 |
| 2026-09-04 | -9.77 |
| 2026-09-03 | -9.88 |
| 2026-09-02 | -10.14 |
| 2026-09-01 | -9.36 |
| 2026-08-31 | -9.83 |
| 2026-08-28 | -10.01 |
| 2026-08-27 | -10.63 |
| 2026-08-26 | -11.42 |
| 2026-08-25 | -10.48 |
| 2026-08-24 | -9.47 |
| 2026-08-21 | -9.94 |
| 2026-08-20 | -8.97 |
| 2026-08-19 | -9.53 |
| 2026-08-18 | -8.34 |
| 2026-08-17 | -8.68 |
| 2026-08-14 | -8.96 |
| 2026-08-13 | -8.88 |
| 2026-08-12 | -9.04 |
| 2026-08-11 | -9.07 |
| 2026-08-10 | -9.28 |
| 2026-08-07 | -8.77 |
| 2026-08-06 | -8.25 |
| 2026-08-05 | -8.50 |
| 2026-08-04 | -8.49 |
| 2026-08-03 | -8.22 |
| 2026-07-31 | -7.91 |
| 2026-07-30 | -7.96 |
| 2026-07-29 | -7.61 |
| 2026-07-28 | -7.85 |
| 2026-07-27 | -8.29 |
| 2026-07-24 | -8.21 |
| 2026-07-23 | -8.33 |
| 2026-07-22 | -7.98 |
| 2026-07-21 | -7.89 |
| 2026-07-20 | -7.39 |
| 2026-07-17 | -7.53 |
| 2026-07-16 | -7.45 |
| 2026-07-15 | -7.84 |
| 2026-07-14 | -7.89 |
| 2026-07-13 | -7.99 |
| 2026-07-10 | -7.99 |